Yuanzhe Guan is a Scientist 2 at Genentech, with a strong background in cell and gene therapy, having previously served as Project Lead at AmplifyBio. In that role, Yuanzhe led the scale-up of allogeneic TCR T-cell therapies for solid tumors and engineered functional T cell receptors to enhance gene editing efficiency. Yuanzhe's academic background includes a Master's degree in Chemistry & Biochemistry from the University of Delaware and a Master of Science in Biology from Adelphi University. Previous experience includes significant contributions to R&D at Mirimus, Inc., where Yuanzhe developed innovative gene editing pipelines and managed product development, as well as experience in teaching and research assistance at universities. Key skills encompass molecular cloning, cell culture, and statistical analysis.